Business Context and Reporting Period
This Form 8-K is a current report filed by NanoVibronix, Inc. (trading symbol: NAOV) on June 13, 2019. The registrant is an emerging growth company incorporated in Delaware. The report addresses a specific corporate governance event regarding the company's 2019 Annual Meeting of Stockholders.
Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The document is limited to reporting a procedural event regarding a shareholder meeting.
Material Changes
The primary material event reported is the adjournment of the 2019 Annual Meeting of Stockholders. The meeting, originally scheduled for June 13, 2019, at 10:00 a.m. Eastern Time, failed to achieve the requisite quorum. Consequently, the meeting was rescheduled for June 20, 2019, at 10:00 a.m. Eastern Time, to be held at the offices of Troutman Sanders LLP in New York, New York.
Guidance, Outlook, and Risks
The filing contains no management guidance, financial outlook, or discussion of risks and contingencies beyond the immediate logistical issue of the meeting adjournment. No unusual items or financial contingencies are disclosed in this report.
Key Facts for Investor Verification
- Meeting Status: The 2019 Annual Meeting was adjourned due to a lack of quorum.
- New Date: The rescheduled meeting is set for June 20, 2019.
- Location: The new venue is Troutman Sanders LLP, 875 Third Avenue, New York, NY 10022.
- Company Name Discrepancy: The filing metadata lists "Envue Medical, Inc.", but the document text explicitly identifies the registrant as "NanoVibronix, Inc." Investors should verify the correct entity name.
- Financial Data: No financial performance data is available in this specific filing.